Huafeng Xie

Second Affiliated Hospital of Guangzhou Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index5.0kcitations89works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(41), Epigenetics and DNA Methylation(39), Genomics and Chromatin Dynamics(9), Acute Myeloid Leukemia Research(8), Immune cells in cancer(6)

Publications89 total

PRC2-regulated glycolysis-to-oxphos metabolic switch coordinates the onset of terminal erythropoiesis
Blood·2025Open Access
PU.1: C/EBPα ratio-directed reprogramming converts B-ALL cells into stable M1 macrophages for scalable cancer immunotherapy
Blood·2025
Polycomb Repressive Complex 2 Regulates Differentiation-Stage-Specific Autophagy Gene Expression and Safeguards Normal Erythropoiesis
Blood·2024
Bone marrow CD8+ Trm cells induced by IL-15 and CD16+ monocytes contribute to HSPC destruction in human severe aplastic anemia
Clinical Immunology·2024· 3 cited
Supplementary Figure 3 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure Legends from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Data from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure Legends from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Table 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Table 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 4 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 5 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Table 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Data from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Figure 5 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
Supplementary Table 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Stuart H. Orkin(26), Yuko Fujiwara(11), Stuart H. Orkin(8), Woojin Kim(8), Thomas Graf(7), Bin E. Li(7), Jialiang Huang(6), Jian Xu(5), Jessie Hao-Ru Hsu(5), Minh Nguyen(5), Pingzhu Zhou(5), William T. Pu(5), Jialiang Huang(5), Catherine V. Laiosa(4), Jun Qi(4), Benjamin Hubbell-Engler(4), Guillaume Adelmant(4), Cailin E. Joyce(4), Francisca Vázquez(4), Barbara A. Weir(4)